IASO Biotherapeutics recently announced the completion of US$60 million in series B financing led by GL Ventures, a venture capital fund of Hillhouse Capital focusing on early-stage innovative companies.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
